Masahiro Yamazaki
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial.
Journal: Journal of diabetes investigation
Published: April 10, 2026
Prediction of Postprandial Blood Glucose Variability Using Machine Learning in Frequent Insulin Injection Therapy with a Simplified Carbohydrate Counting Model.
Journal: Nutrients
Published: October 13, 2025
Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study).
Journal: BMJ open
Published: March 03, 2025
Changes in food preferences after oral semaglutide administration in Japanese patients with type 2 diabetes: KAMOGAWA-DM cohort.
Journal: Diabetes & vascular disease research
Published: January 29, 2025
Increased Insulin Requirements in Severe Cases of Covid-19 are Higher Than in Moderate Cases.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 30, 2024
Relationship between diabetes diet-related quality of life and dietary fiber intake among people with type 2 diabetes: a cross-sectional study.
Journal: Endocrine journal
Published: March 31, 2024
Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes.
Journal: Journal of diabetes investigation
Published: January 04, 2024
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study.
Journal: Diabetes & vascular disease research
Published: December 08, 2023
Postoperative Insulin Dose for Cardiac Artery Bypass Graft and Other Cardiac Surgeries in Patients with Type 2 Diabetes: A Retrospective Study.
Journal: Vascular health and risk management
Published: October 28, 2023
Younger patients and low c-peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium-glucose cotransporter 2 inhibitor administration.
Journal: Diabetes, obesity & metabolism
Published: June 30, 2023
Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort.
Journal: Diabetes research and clinical practice
Published: April 27, 2023
Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus.
Journal: Journal of diabetes investigation
Published: February 27, 2023
Last Updated: 09/26/2026